PSA Test - More Harm Than Good For Prostate Cancer Screening
Thursday, January 1, 2015 - 20:00
in Health & Medicine
New prostate screening guidelines recommend that the prostate-specific antigen (PSA) test not be used to screen for prostate cancer based on evidence that shows uncertain benefits and an increased risk of harm. Prostate cancer is the most commonly diagnosed non-skin cancer in men and the third most common cause of death from cancer in men in Canada and elsewhere. In modern times, the prognosis for most prostate cancers is good with a 10-year survival rate of 95%. Prostate cancer is generally slow to progress and today is usually not life-threatening. read more